BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16497186)

  • 21. Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle.
    Li W; Tonelli J; Kishore P; Owen R; Goodman E; Scherer PE; Hawkins M
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1301-7. PubMed ID: 17213476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity.
    Kraegen EW; Cooney GJ; Ye JM; Thompson AL; Furler SM
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S189-201. PubMed ID: 11460570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
    Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
    Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance.
    Blaak EE
    Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):391-403. PubMed ID: 16150382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
    Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
    Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity.
    Dulloo AG
    Horm Res; 2006; 65 Suppl 3():90-7. PubMed ID: 16612120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of type 2 diabetes.
    Scheen AJ
    Acta Clin Belg; 2003; 58(6):335-41. PubMed ID: 15068125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue.
    Eringa EC; Bakker W; van Hinsbergh VW
    Vascul Pharmacol; 2012; 56(5-6):204-9. PubMed ID: 22366250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [From obesity to diabetes].
    Stöckli R; Keller U
    Ther Umsch; 2002 Aug; 59(8):388-92. PubMed ID: 12235730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus.
    Maassen JA; Romijn JA; Heine RJ
    Diabetologia; 2007 Oct; 50(10):2036-41. PubMed ID: 17712547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fat cell enlargement is an independent marker of insulin resistance and 'hyperleptinaemia'.
    Lundgren M; Svensson M; Lindmark S; Renström F; Ruge T; Eriksson JW
    Diabetologia; 2007 Mar; 50(3):625-33. PubMed ID: 17216279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Link between obesity and type 2 diabetes.
    Golay A; Ybarra J
    Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):649-63. PubMed ID: 16311223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipose tissue renin-angiotensin-aldosterone system (RAAS) and progression of insulin resistance.
    Marcus Y; Shefer G; Stern N
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):1-14. PubMed ID: 22750719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of cardiac fat in insulin resistance.
    Gastaldelli A; Morales MA; Marraccini P; Sicari R
    Curr Opin Clin Nutr Metab Care; 2012 Nov; 15(6):523-8. PubMed ID: 23037899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased fat intake, impaired fat oxidation, and failure of fat cell proliferation result in ectopic fat storage, insulin resistance, and type 2 diabetes mellitus.
    Ravussin E; Smith SR
    Ann N Y Acad Sci; 2002 Jun; 967():363-78. PubMed ID: 12079864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum Orosomucoid Is Associated with Serum Adiponectin, Adipose Tissue Insulin Resistance Index, and a Family History of Type 2 Diabetes in Young Normal Weight Japanese Women.
    Honda M; Tsuboi A; Minato-Inokawa S; Takeuchi M; Kurata M; Takayoshi T; Hirota Y; Wu B; Kazumi T; Fukuo K
    J Diabetes Res; 2022; 2022():7153238. PubMed ID: 35103244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.
    Kahn SE
    Diabetologia; 2003 Jan; 46(1):3-19. PubMed ID: 12637977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of leptin and adiponectin on pancreatic β-cell function.
    Lee YH; Magkos F; Mantzoros CS; Kang ES
    Metabolism; 2011 Dec; 60(12):1664-72. PubMed ID: 21632069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Metabolic syndrome: from insulin resistance to adipose tissue dysfunction].
    Camera A; Hopps E; Caimi G
    Minerva Med; 2008 Jun; 99(3):307-21. PubMed ID: 18497727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.